View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Project
15 February 2018

Siemens Healthineers Facility Expansion, Walpole, Massachusetts

In June 2017, Germany-based medical technology company Siemens Healthineers began an expansion and refurbishment of its laboratory diagnostic manufacturing facility in Walpole, Massachusetts.
Artist’s rendering of the new laboratory diagnostic manufacturing facility in Walpole, Massachusetts. Credit: Siemens.
A ground-breaking ceremony for the facility's construction was held in June 2017. Credit: Siemens.
The facility will be expanded by an additional 300,000ft². Credit: Siemens.

In June 2017, Germany-based medical technology company Siemens Healthineers began an expansion and refurbishment of its laboratory diagnostic manufacturing facility in Walpole, Massachusetts.

Free eBook
img

3 Key Tips for a Successful Design Build Project

With supply chain disruptions and inflation creating new challenges for delivery teams, design-build projects are booming. This e-book looks at the 3 essential tips a project delivery team must consider when delivering a successful Design Build project.
by Oracle
Enter your details here to receive your free eBook.

Estimated to cost $300m, the expanded facility will be used to manufacture the company’s Atellica Solution. The expansion is scheduled to be completed within three years.

The project is in line with Siemens’ strategic growth plans and is expected to increase the area’s property tax revenue by around $10m over the next 20 years.

The project is expected to create 700 jobs over the next ten years, increasing the facility’s total number of employees to 1,600 by 2026.

Siemens Healthineers Walpole facility expansion details

Siemens Healthineers’ existing 500,000ft² manufacturing facility will be expanded by an additional 300,000ft² as part of the project.

The additional space will include more manufacturing spaces, a warehouse, office spaces and a laboratory complex.

The facility will be used to produce laboratory diagnostics assays for immunoassay instruments, as well as consumables for molecular and blood gas testing instruments.

“The facility will be used to produce laboratory diagnostics assays for immunoassay instruments.”

The expansion will be undertaken in multiple phases. The topping-off of the building’s steel frame structure was completed in January 2018.

Products produced at the expanded Walpole facility

The expanded facility will produce the Atellica™ solution. This solution is a flexible, scalable and automation-ready immunoassay and chemistry analyser.

The solution allow laboratory diagnostics professionals to spend more time driving outcomes and less time on operations. It is designed to overcome common clinical laboratory challenges and combine immunoassay and clinical chemistry analysers to deliver better outcomes.

Financing for the Walpole facility expansion

The local governments of Massachusetts are offering investment incentives for the expansion project.

The Commonwealth of Massachusetts is providing job creation tax incentives through the Massachusetts Life Sciences Centre and infrastructure support under the MassWorks and workforce training grants.

Walpole is also supporting the project through tax increment financing and property tax abatement.

Contractors involved in the project

In July 2017, US-based technical consultant Jacobs Engineering Group was given a contract to provide engineering and construction support for the expansion project.

The work includes masterplan development for production capacity enhancement, the expansion of office and laboratory spaces and the addition of a warehouse at the existing facility.

Marketing commentary on Siemens Healthineers

Siemens Healthineers offers products and services in the areas of diagnostics, imaging and molecular medicine. The company produces 10 billion diagnostic tests a year.

The company, which employs 46,000 people worldwide, also develops digital health and enterprise services.

Established in 1979, Siemens’ Walpole manufacturing facility is one of the company’s 60 manufacturing sites in the US. The facility underwent an initial expansion in 2007 and was selected for further expansion due to the advantages the location offers in terms of infrastructure and manufacturing costs.

Financial support provided by the Commonwealth of Massachusetts and Massachusetts Life Sciences Centre also contributed to the decision to expand the facility.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology